Salmi HA, Sarna S. Effect of silymarin on chemical, functional and morphological alterations of the liver. A double-blind controlled study.
Scand J Gastroenterol.
1982;17:517 - 521.
Feher J, Desk G, Muzes G, et al. Liver protective action of silymarin therapy in chronic alcoholic liver diseases [in Hungarian].
1989;130:2723 - 2727.
Fintelmann V, Albert A. Proof of the therapeutic efficacy of LegalonW for toxic liver illnesses in a double-blind trial [translated from German].
1980;30:5589 - 5594.
Trinchet JC, Coste T, Levy VG, et al. Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients [translated from French].
Gastroenterol Clin Biol.
1989;13:120 - 124.
Bunout D, Hirsch SB, Petermann MT, et al. Controlled study of the effect of silymarin on alcoholic liver disease [translated from Spanish].
Rev Med Chil.
1992;120:1370 - 1375.
Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.
1989;9:105 - 113.
Benda L, Dittrich H, Ferenzi P, et al. The influence of therapy with silymarin on the survival rate of patients with liver cirrhosis [translated from German].
Wien Klin Wochenschr.
1980;92:678 - 683.
Pares A, Planas R, Torres M, et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.
1998;28:615 - 621.
Lang I, et al. Hepatoprotective and immunological effects of antioxidant drugs.
Tokai J Exp Clin Med.
1990;15:123 - 127.
Lang I, et al. Immunomodulatory and hepatoprotective effects of in vivo treatment with free radical scavengers.
Ital J Gastroenterol.
1990;22:283 - 287.
Lucena MI, Andrade RJ, de la Cruz JP, et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study.
Int J Clin Pharmacol Ther.
2002;40:2 - 8.
Rambaldi A, Gluud C. S-adenosyl-L-methionine for alcoholic liver diseases.
Cochrane Database Syst Rev
Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.
1999;30:1081 - 1089.
Barak AJ, Beckenhauer HC, Tuma DJ. Betaine, ethanol and the liver: a review.
1996;13:395 - 398.
Barak AJ, Beckenhauer HC, Junnila M, et al. Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration.
Alcohol Clin Exp Res.
1993;17:552 - 555.
Murakami T, Nagamura Y, Hirano K. The recovering effect of betaine on carbon tetrachloride-induced liver injury.
J Nutr Sci Vitaminol.
1998;44:249 - 255.
Kanbak G, Inal M, Baycu C. Ethanol-induced hepatotoxicity and protective effect of betaine.
Cell Biochem Funct.
2001;19:281 - 285.
Lieber CS, DeCarli LM, Mak KM, et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin.
1990;12:1390 - 1398.
Lieber CS, Leo MA, Mak KM, et al. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity.
1985;5:561 - 572.
Lieber CS, Rubin E. Alcoholic fatty liver.
N Engl J Med.
1969;280:705 - 708.
Schuller-Perez A, Gonzalez San Martin F. A controlled study with polyunsaturated phosphatidylcholine compared to placebo in alcoholic steatosis of the liver [translated from German].
1985;36:517 - 521.
Knuchel F. Double-blind study in patients with alcoholic toxic fatty liver. Effect of essential phospholipids on enzyme behavior and lipid composition of the serum [translated from German].
1979;30:411 - 416.
Keung WM, Vallee BL. Kudzu root: an ancient Chinese source of modern antidipsotropic agents.
1998;47:499 - 506.
Shebek J, Rindone JP. A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism.
J Altern Complement Med.
2000;6:45 - 48.
Bullock ML, Kiresuk TJ, Sherman RE, et al. A large, randomized, placebo-controlled study of auricular acupuncture for alcohol dependence.
J Subst Abuse Treat.
2002;22:71 - 77.
Sapir-Weise R, Berglund M, Frank A, et al. Acupuncture in alcoholism treatment: a randomized out-patient study.
1999;34:629 - 635.
Worner TM, Zeller B, Schwarz H, et al. Acupuncture fails to improve treatment outcome in alcoholics.
Drug Alcohol Depend.
1992;30:169 - 173.
Bullock ML, Umen AJ, Culliton PD, et al. Acupuncture treatment of alcoholic recidivism: a pilot study.
Alcohol Clin Exp Res.
1987;11:292 - 295.
Bullock ML, Culliton PD, Olander RT. Controlled trial of acupuncture for severe recidivist alcoholism.
1989;1:1435 - 1439.
Akhondzadeh S, Kashani L, Mobaseri M, et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J
Clin Pharm Ther.
2001;26:369 - 373.
Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity.
Am J Clin Nutr.
1999;69:1071 - 1085.
Ni R, Leo MA, Zhao J, et al. Toxicity of beta-carotene and its exacerbation by acetaldehyde in HepG2 cells.
2001;36:281 - 285.
33Veh I, Chatterjee SS, Kiianmaa K, et al. Reduction of voluntary ethanol intake in alcohol-preferring AA-rats by kava extract. Presented at International Congress and 49th Meeting of the Society for Medicinal Plant Research; September 2 - 6, 2001; Erlangen, Germany.
Markowitz JS, McRae AL, Sonne SC. Oral nutritional supplementation for the alcoholic patient: a brief overview.
Ann Clin Psychiatry.
European Scientific Cooperative on Phytotherapy.
Exeter, UK:ESCOP;1996-1997:2. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 4.
Chan TY, Tang CH, Critchley JA. Poisoning due to an over-the-counter hypnotic, Sleep-Qik (hyosine, cyproheptadine, valerian).
Postgrad Med J.
Chan TY. An assessment of the delayed effects associated with valerian overdose [letter].
Int J Clin Pharmacol Ther.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
Wellmont LiveWell is creating a new tradition of wellness in the mountains by providing individuals with tools and encouragement to live healthier lifestyles.
Fight heart disease early and prevent heart attacks with HeartSHAPE® - a painless, non-invasive test that takes pictures of your heart to scan for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.